Targeting a turnover of Rs 1000 crore by FY2017, bothers Alok and Anuj are determined to take their father Jagdish…
Pharma exports grew at just 1.2 per cent in FY 2014. Can the latest Foreign Trade Policy galvanise creation of…
SGK Kishore, CEO, GMR Hyderabad International Airport Ltd (GHIAL), talks about the success of the pharma zone at the GMR…
Automation of clinical laboratories is just the beginning of a new era that has started with the initiation of programmable…
India’s ancient holistic healing traditions take centre stage on the first World Yoga Day. But the AYUSH sector is riddled…
Maharashtra Ayurved Centre, which has just begin operations, has ambitious plans of bringing the benefits of Ayurveda to the masses.…
Regulatory woes continue to plague the AYUSH sector in India and hamper its progress despite measures to revive the traditional…
Sane Care Madhavbaug uses a blend of yoga and ayurveda to treat heart patients. Its scientifically proven methods have not…
A nine-year old nutritional bar manufacturing company, Naturell India has introduced various healthy bars to the Indian market. Vijay Uttarwar,…
Established in 1935, Ayurveda Rasashala, based in Pune, is one of the oldest pharmacies manufacturing ayurvedic medicines. Shalini Gupta finds…
Dr Yogesh M Jirankalgikar, Lecturer, Dept of Basic Principles,SHES’ AMC Ayurveda Medical College, Gulbarga, and Dr Pravin R Joshi, Lecturer,…
Following PM Modi’s vision of ‘zero defect’, ‘zero effect’, pharmaceutical companies supported the Swachh Bharat campaign. The government too is…
Pithampur site was pharma industry’s first LEED India gold rated manufacturing facility
Seminar in Hyderabad organised by GCF in collaboration with DoP, TSPCB and BDMA
RC Juneja’s Mankind Pharma ranks fifth in India’s pharma market but can he take it beyond flagship brand Manforce? By…
The government plans to re-brand the Jan Aushadhi initiative by opening 1000 centres across India by this June. Will this…
HLL Biotech launched two vaccines this year and is also working full throttle towards reviving three vaccine-manufacturing PSUs. Does it…
Since 2013, Novartis has sharpened focus, with last April’s asset swaps with GSK and Eli Lilly the next step in…